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M.F. Caruana, A.W. Bradbury and D.J. Adam*University Department of Vascular Surgery, Birmingham Heartlands Hospital, Birmingham, UKBackground. Despite the increasing sophistication of vascular surgical practice, more than three decades after its
introduction to clinical practice, the ankle to brachial pressure index (ABPI) remains the cornerstone of non-invasive
assessment of the patient with symptomatic peripheral arterial disease (PAD).
Aim. To summarise what is known about ABPI and critically appraise its validity, reliability, reproducibility and extended
utility.
Methods. A MEDLINE (1966–2004) and Cochrane library search for articles relating to measurement of ABPI was
undertaken; see text for further details.
Results. There is considerable disagreement as to how ABPI should be measured. Furthermore, various factors, including
the type of equipment used, and the experience of the operator, can result in significant inter- and intra-observer error. As
such, care must be taken when interpreting data in the literature. ABPI is valuable in the assessment of patients with
atypical symptoms, venous leg ulcers and after vascular and endovascular interventions. However, absolute pressures are
probably more valuable in patients with critical limb ischaemia. ABPI is also useful in subjects with asymptomatic PAD
where it correlates well with, and may be used in screening studies to quantify, cardiovascular risk.
Conclusions. While its apparent simplicity can beguile the unwary, ABPI will continue to have a key role in the assessment
of symptomatic PAD. ABPI is also likely to have extended utility in health screening and institution of best medical therapy
in asymptomatic subjects.Keywords: Ankle brachial pressure index; Peripheral arterial disease.Introduction
Despite the increasing sophistication of vascular
surgical practice, more than three decades after its
introduction into clinical practice, the ankle to brachial
pressure index (ABI or ABPI) remains the cornerstone
of non-invasive assessment of the patient with
symptomatic peripheral arterial disease (PAD). While
Travis Winsor was the first to report in 1950 that the
ankle pressure is usually decreased if the arteries in
the lower limb are obstructed, Yao from St Mary’s
Hospital in London was the first to report in 1970 that
the severity of disease correlated to the drop in theing author. Mr D.J. Adam, Research Institute, Birming-
nds Hospital, Lincoln House, Bordesley Green East,
B9 5SS, UK.
: donald.adam@heartsol.wmids.nhs.uk
0443+ 09 $35.00/0 q 2005 Elsevier Ltd. All rights reserABPI.1 More recently, it has been developed as an
epidemiological tool for defining the natural history of
PAD. Furthermore, ABPI is likely to play a key role in
screening for individuals with asymptomatic PAD
who are at high cardiovascular risk and would benefit
from lifestyle advice and ‘best medical therapy’
(BMT).2,3 The purpose of this review is to critically
appraise the validity, reliability, reproducibility and
extended utility of the ABPI in clinical practice, and as
a research tool, in primary and secondary care.Methods
A MEDLINE (1966–2004) and Cochrane library search
looking for articles relating to ABPI was performed.
The terms ankle pressure, ABI, ABPI, ankle arm indexEur J Vasc Endovasc Surg 29, 443–451 (2005)
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angioplasty were amongst those included. These were
linked with terms such as cardiovascular disease,
diabetes and PAD. Further articles were identified by
following MEDLINE links, by cross-referencing from
the reference lists of major articles and by following
citations for these studies. The studies were then
graded with highest priority given according to the
level of evidence.ResultsABPI methodology
Several methods for measuring ABPI have been
described.4 As well as producing different results in
individual patients, these different methodologies are
open to different forms of bias and will, therefore, be
associated with different levels of reproducibility
depending on the clinical circumstances. The higher
of the two pressures in the dorsalis pedis (DP) or the
posterior tibial (PT) arteries (or the peroneal artery if
no audible signal is forthcoming from these two
vessels) is conventionally taken as the ABPI numerator
and the higher of the two brachial pressures as the
denominator. In the absence of significant stenosis or
occlusion in these vessels the two values are usually
within 10 mmHg of each other5 even in the presence of
more proximal disease. Other workers have suggested
that averaging the DP and PT pressures correlates
more closely with limb function.6 Sometimes brachial
blood pressures are averaged and/or the brachial
pressure is only measured in one arm; usually the
right.7,8 It is worth noting that a pressure difference
between the right and left brachial arteries of at least
20 mmHg is present in 3.5% of the normal healthy
population8,9 and over 20% of patients with PAD.10 As
such, the pressure should be measured in both arms.
Although the higher of the two pressures will most
closely reflect central aortic pressure, it is possible for
patients with PAD to have bilateral subclavian-axillary
artery occlusive disease although the precise incidence
of this situation is difficult to determine. In these
circumstances, both brachial pressures will be artifi-
cially low and the ABPI artificially elevated.
Another potential source of variability, particularly
in longitudinal studies, is the non-linear relationship
between the central and ankle systolic pressures and
between central pressure and ABPI.10 In other words,
for the same degree of lower limb disease, ABPI will be
relatively lower in the presence of hypertension.11–13
Furthermore, as hypertension is treated the ABPI willEur J Vasc Endovasc Surg Vol 29, May 2005appear to ‘improve’. Finally, given the phenomenon of
‘white coat hypertension’, it is likely that the ABPI
measured by a vascular surgeon in hospital will
appear lower that it would when measured by a
nurse in the patient’s own home. It is wise, therefore,
to record the absolute brachial and ankle pressures as
well as ABPI.
The method used to measure the brachial arterial
pressure also significantly affects the ABP1.14 As
mercury sphygmomanometers are gradually phased
out of clinical practice due to safety concerns,
automated devices using the oscillometric principle
(e.g. Dinamap) are becoming increasingly popular.15
Some studies suggest that the brachial and ankle
pressures can be accurately obtained using these
devices, and values closely resemble those obtained
using a pneumatic cuff and Doppler probe.16,17 This
fact, however, is not universally accepted. Indeed, in
one blinded study there was no correlation between
values obtained from all four limbs using the standard
Doppler technique and those obtained by an auto-
mated oscillometric device.18,19
The technique used to measure the brachial systolic
pressure can also influence the value of the ABPI.18,20
Use of oscillometric devices tends to overestimate the
systolic blood pressure when compared to using a
standard sphygmomanometer and this discrepancy is
more pronounced in subjects with stiff arteries.21 This
methodological variability is not limited to ABPI. Toe
pressures and cutaneous oxygen tension measure-
ments are also significantly affected, particularly when
taken from the second toe rather than the hallux.22The importance of blood pressure cuff position
It is worth re-emphasising that the ‘ankle pressure’ is
actually the pressure under the cuff where it is
positioned on the calf and not where the Doppler
probe is positioned at the ankle. In patients with crural
disease the recorded ABPI may, therefore, vary
significantly depending on whether the cuff is placed
proximally over the bulk of the calf muscles, as may be
the case in a patient with a circumferential ulcer, or
distally, just proximal to the malleoli.23 This may lead
to inappropriate clinical decision making; for example,
regarding the use of compression in patients with
mixed arterial and venous ulcers. It is also worth
pointing out that as the ABPI is based upon the highest
of the three ankle pressures it ‘puts the best light’ on
the perfusion of the foot. For example, a patient with
occlusion of PT and peroneal arteries but a relatively
normal anterior tibial artery may appear to have an
adequate ABPI and yet have little or no perfusion of
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patients with diabetes often have segmental crural and
pedal arterial disease resulting in very different levels
of perfusion in different parts of the foot. Furthermore,
ABPI may be falsely elevated because the arterial
disease is distal to the cuff and even the Doppler
probe.The importance of blood pressure cuff size
Cuff size has an important effect on the indirect
measurement of blood pressure. Specifically, larger
cuffs should be used in the obese so as to avoid over-
estimating systolic brachial blood pressure and thus
under-estimating ABPI.24 Provided that the cuff is
placed as distally as possible on the calf, this may be
less of an issue in the measurement of ankle pressures
as even the morbidly obese tend not to have fat
ankles.25 However, it is highly relevant in patients
with oedema (lymphoedema and venous oedema) and
in children.26 Most clinicians tend to opt for a cuff that
is as wide as two-thirds to three-quarters of the upper
arm length and this has been shown to significantly
under-estimate both the systolic and diastolic blood
pressure when compared to measurements obtained
directly via a radial artery transducer. Early work in
this field by Geddes et al. has shown that using a cuff
with a bladder width of 40% of the upper arm
circumference gives a more accurate estimate of the
systolic blood pressure.24 In neonates and infants the
ABPI is physiologically lower than in older children
and adult values are reached during the second year of
life.27 The above facts must be kept in mind both when
assessing young infants for instance following iatro-
genic catheterisation injuries and when such patients
are followed up into later childhood.Reproducibility of ABPI
The significance of ABPI reproducibility, or lack of it,
depends upon the context in which it is being used.
For example, as inter-observer variability is consider-
ably less than the biological variability between
normal subjects and those affected by different stages
of disease, lack of reproducibility is generally not an
issue in epidemiological studies.28 This is not necess-
arily the case when ABPI is being used to define the
natural history of PAD or treatment outcomes in
individual patients being studied longitudinally. In
these circumstances, multiple measurements both at
baseline and during follow-up are recommended.29,30
For example, one hospital-based study found that 30%
of the ABPIs performed by junior doctors wereincorrect when compared to the values obtained by
vascular technicians; this figure improved to 15% after
formal training.31 This may partially relate to the fact
that within the vascular laboratory, the brachial
systolic pressure is more likely to be estimated using
a Doppler probe, whereas house officers tend to rely
on the Korotkoff method20 which tends to yield lower
values for the systolic pressure. Significant variability
between measurements depending upon degree of
experience has also been shown in other more recent
studies.29,32 The impact of both inter-observer and
intra-observer error on reproducibility has been
quantified in a Dutch general practice based study.33
When the ABPI was used to follow up patients with
PAD, the difference between two sequential ratios had
to be at least 19% in order to exclude an intra-observer
error. This reaffirms the generally accepted notion that
the ABPI must change by at least 0.15 before this can
be considered to be clinically significant.30Implications of variability and methodology for practice
Taken together the various factors influencing the
measurement and reproducibility of ABPI can have a
profound effect upon the data being collected and
recorded for clinical practice, as well as scientific
reporting. While there may not be ‘one best way’ of
measuring ABPI, it is important that individual
clinical units and research teams:& Formally train their observers (whether they be
doctors, nurses, or technologists) using a standar-
dised methodology& Record their results in a standardized manner for
day to day clinical practice& State their preferred method explicitly when
reporting in the literature& Audit their results34to ensure that the apparent simplicity of the ABPI
does not beguile them in to making inappropriate
clinical decisions, drawing erroneous conclusions with
regard to the outcome from vascular interventions, or
publishing spurious data.Association between ABPI and clinical stage of PAD
In the aggregate, ABPI correlates well with the
angiographic severity of lower limb arterial occlusive
disease5,35 and the resulting functional impairment
both objectively and as perceived by the patient.36 In
healthy individuals the ABPI is usually 1.0–1.2 in the
supine position.36,37 The peak systolic ankle pressureEur J Vasc Endovasc Surg Vol 29, May 2005
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of pressure augmentation by the muscular peripheral
arteries as well as the summation of reflected pressure
waves.38 As stressed below, ankle pressures must be
measured with the patient supine, not least because of
the veno-arteriolar reflex. In healthy individuals,
standing up activates this reflex which leads to
arteriolar vasoconstriction and an overall restriction
in arterial flow.39 This mechanism is significantly
impaired in patients with SCLI and CLI,40 chronic
venous disease and in diabetics with autonomic
neuropathy. Patients with intermittent claudication
(IC) usually have an ABPI of 0.5–0.8 while those with
sub-critical (SCLI)41 and critical limb ischaemia (CLI)
usually have ABPI of!0.5 and!0.3, respectively. The
association between disease severity and the ABPI
applies not only to hospital patients, but also to
community-based studies.1 However, there can be
considerable overlap in ABPI between these major
clinical groups and, as with many clinical measure-
ments, it is the trend over time, rather than the
absolute index, that is most clinically important on an
individual patient basis.
A significant number of patients presenting to
vascular clinics can be difficult to assess2,42,43 either
because they have:&EurPAD with atypical symptoms or
& other pathology (e.g. spinal stenosis) to explain
their leg symptoms in the presence of asympto-
matic PADABPI can be particularly helpful in such circum-
stances by allowing the clinician to correlate the
patient’s subjective symptoms with an objective
measure of arterial disease severity.Value of ABPI in critical limb ischaemia
In patients with potentially limb-threatening ischae-
mia there appears to be a better relationship between
symptoms, limb viability, treatment opportunities and
outcome and absolute pressures than there is with
ABPI.44–46 A review of the results of 20 publications
reporting 6118 patients,41 demonstrated that patients
with SCLI (defined as rest pain and/or an absolute
ankle pressure of more than 40 mmHg) were at
significantly lower risk of limb loss than patients
with CLI (tissue loss or an absolute ankle pressure of
less than 40 mmHg). However, while easy to recognise
clinically, CLI has proved surprisingly difficult to
define for purposes of scientific reporting. The
European Consensus Document definition of CLI,J Vasc Endovasc Surg Vol 29, May 2005which remains controversial and is by no means
strictly observed in the literature,47 includes an
absolute ankle pressure !50 mmHg or toe pressure
less than 30 mmHg.48 The latter is also included in the
Trans-Atlantic Inter-Society Consensus recommen-
dations and is recommended for patients with
calcified crural arteries.44 However, toe pressures
have a low positive and a high negative predictive
value when used to detect CLI and are, therefore, more
useful in the exclusion of CLI than its confirmation.44
See section on the ‘pole test’ below.ABPI and chronic venous ulceration
In patients with chronic venous ulceration (CVU), it is
currently recommended that the ABPI should beO0.8
if compression bandaging is to be applied safely in the
community.49 This is a major issue with district and
practice nurses increasingly referring patients with
CVU to vascular clinics for measurement of ankle
pressures and ABPI; or for confirmation of ankle
pressures and ABPI measured in primary care. ABPI
in patients with CVUmust be interpreted with caution
for a number of reasons:† In patients with low central systolic pressure, or in
whom this is underestimated because of PAD in the
upper extremity, the ABPI under-represents the
degree of arterial disease in the lower extremity.50
Absolute systolic ankle pressures may be more
meaningful in this situation.† The ABPI is representative of the highest systolic
pressure measured at the ankle. In patients where
individual calf vessels are heavily diseased or
occluded while a single tibial vessel is relatively
preserved, the ABPI would fail to indicate the fact
that part of the calf may be significantly under-
perfused and, therefore, more susceptible to press-
ure damage. A difference of O10 mmHg5 between
systolic pressure readings taken from different
pedal vessels should alert the clinician to this
possibility.† The ABPI may be inaccurate if the cuff is placed
proximally over the bulk of the calf muscles, as may
be the case in a patient with a circumferential
ulcer.23 This may lead to inappropriate use of
compression therapy in patients with mixed
arterio-venous ulcers.Non-compressibility of vessels
Many patients with PAD, particularly those with
diabetes and end-stage renal failure, have calcified
Ankle to Brachial Pressure Index 447and incompressible crural vessels leading to spur-
iously elevated ABPI.51 The degree to which the ABPI
can be raised is variable and difficult to quantify, once
again emphasising the need to interpret the index in
the light of clinical findings and other investigations. If
there is doubt about the validity of the ABPI then two
alternatives are to use toe pressures to calculate the
TBPI52,53 or to utilize the ‘pole test’.54,55 In the latter,
with the patient supine, the foot is elevated against a
calibrated pole. The height above the heart at which
the ankle or toe Doppler signal disappears approxi-
mates the perfusion pressure at the site of the probe in
centimetres of water fromwhich a value in mmHg can
be derived (1.36 cm of water equals 1 mmHg). In
practice, if the Doppler signals are still present at the
ankle with the hip elevated to 908 then this effectively
excludes CLI (i.e. the perfusion pressure exceeds
50 mmHg) and is a useful semi-quantitative screening
test.Effect of exercise on the ABPI
Exercise results in local vasodilation and this rapidly
overcomes the vasoconstrictive response to postural
changes. In normal individuals this results in a
significant increase in the total blood flow and the
blood pressure is maintained.37 This increased flow
would amplify the resistance across both a significant
stenosis in an arterial trunk feeding the intramuscular
arterioles and across a collateral system bypassing an
occluded artery. Consequently, the pressure in a
vascular bed distal to such a lesion would fall and
remains low while exercise continues and until the
local vasodilator mediators are washed out of the limb.
This explains how the presence of mild to moderate
PAD causes the ABPI to drop after exercise and why
the length of the recovery period is proportional to the
severity of the disease. To obtain a true resting ABPI, it
is necessary for the patient to rest supine for 10–20 min
after walking to the clinic.ABPI and the outcome of vascular surgery
It is widely accepted that successful aorto-iliac and
infra-inguinal arterial reconstruction is accompanied
by a significant increase in ABPI.37 The magnitude as
well as time scale over which this increase occurs
depends very much upon the extent of the underlying
disease as well as the type and extent of intervention.35
For instance, following an aorto-bifemoral bypass for
isolated iliac vessel disease, one would expect a near
instantaneous rise in the ABPI to normal.56 Following
a femoro-popliteal bypass the rise in ABPI may takeup to 4 h to complete, and after profundaplasty this
may take over 24 h. Indeed, there is some evidence
that ABPI may continue to rise for several months
following successful surgery.35
Serial ABPI measurement alone has been shown to
have a very low positive predictive value for vein graft
occlusion following infra-inguinal bypass.57 It is also
insensitive in predicting impending graft failure. In
one study only 38% of limbs demonstrated an ABPI
drop of 0.15 or more on graft occlusion.58 Long-term
outcome for aorto-iliac and infra-inguinal bypass
depends primarily upon progression of PAD, and the
ABPI appears to be relatively insensitive in detecting
disease progression when compared to angiography
or duplex scanning.59 Despite these points, a signifi-
cant drop in the ABPI (O0.15) following surgery
should, if clinically indicated, prompt further graft
assessment. This is supported by data from the recent
vein graft surveillance trial (VGST). This European
Multicentre randomised control trial60,61 has shown
that routine duplex graft surveillance is unjustified in
terms of cost and clinical outcome when compared to
standard clinical follow-up and ABPI measurement
followed by selective duplex scanning. The import-
ance of ensuring standardisation and applying local
quality control to ABPI measurement cannot be
overemphasized in this respect.ABPI and the outcome of endovascular intervention
ABPI appears to increase more slowly after successful
angioplasty and may continue to increase for at least a
month after the procedure.62,63 This has been shown to
correlate with changes in flow rate62 and is indepen-
dent of any calf swelling related to reperfusion. This
suggests that relying on a single measurement of ABPI
taken soon after endovascular intervention (or surgical
bypass for that matter) may underestimate the success
of the procedure as well as the deterioration associated
with post-procedural failure or disease progression.63
The ABPI also appears to be relatively insensitive as a
tool for longitudinal studies of patients following
angioplasty. In one prospective study of patients
following successful superficial femoral artery angio-
plasty, deterioration in the ABPI by 0.15 was highly
specific for reocclusion or stenosis but pressure
measurements showed poor sensitivity in detecting
re-stenosis or occlusion.64,65ABPI and the outcome of medical treatment
While intermittent claudication can often be attributed
to specific abnormalities in the arterial tree, theEur J Vasc Endovasc Surg Vol 29, May 2005
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large vessel haemodynamics.66 Various local metabolic
effects distal to a stenosis or occlusion may all play a
role in the progression of the disease independently
from changes in the ABPI: changes in the production
of local vasodilating agents such as adenosine, and
systemic haematologic effects such as impaired fibri-
nolysis and increased blood viscosity may contribute.
Conversely, medical treatment such as cilostazol and
pentoxifylline may improve symptoms without
necessarily affecting the ABPI. Cilostazol is a selective
phosphodiesterase III inhibitor which has beneficial
effects on platelet function and cholesterol metab-
olism, causes vasodilation and inhibits smooth muscle
proliferation.67 Cilostazol has been shown to increase
resting ABPI and improve the post-exercise recovery
time68 but this may not fully represent its therapeutic
effect. For this reason the large trials of cilostazol used
initial claudication distance and absolute claudication
distance as their primary endpoints.69,70
Current evidence would suggest that supervised
exercise programmes for intermittent claudication
are both safe and effective.71 Exercise is postulated
to increase walking distance by enhancing the
oxidative capacity of skeletal muscle cells, increas-
ing the reliance on non-ischaemic muscles and
promoting the development of collateral vessels.66
These effects would be under-represented by
changes in the ABPI and, therefore, endpoints
such as changes in quality of life scores and
treadmill walking distances are of more relevance
for instance when comparing different approaches
to exercise therapy.72
It is clear, therefore, that the ABPI, being a measure
of changes in the pressure gradient within the axial
arteries, cannot be solely and directly used as a marker
for proof of concept or mechanism for new treatment
modalities that act at the molecular level. This point
may become even more relevant in future as newer
treatment modalities emerge aimed at promoting
angiogenesis.ABPI and asymptomatic PAD
The relationship between lower limb symptoms,
ABPI and cardiovascular risk is an important one.
As described above, a normal ABPI at rest does not
exclude the presence of haemodynamically signifi-
cant lower limb atherosclerosis and if there is
strong suspicion that the patient’s symptoms are
vascular in aetiology, then ABPI should be
repeated after exercise testing. Similarly, the
absence of symptoms does not exclude theEur J Vasc Endovasc Surg Vol 29, May 2005presence of significant lower limb PAD. A lack of
lower limb symptoms in the presence of a low
resting or post-exercise ABPI (typically claudica-
tion) may simply be due to the patient’s choice not
to walk, or due to other exercise limiting pathology
(e.g. osteoarthritis, angina, breathlessness) or dia-
betic neuropathy.
It is now quite clear from several large longitudinal
studies (Table 1) that a low ABPI, usually taken as !
0.8 or !0.9, is associated with a marked increase in
cardiovascular events, recurrent events and mortality,
whether lower limb symptoms are present or not.2,8,73–82
Furthermore, the Edinburgh Artery Study has shown
that even a near-normal ABPI (0.91–1.0) is associated
with reduced 5 year survival.8
The data shown in Table 1 suggests that ABPI can be
used in primary care to screen for early asymptomatic
and symptomatic PAD. The institution of BMT in such
individuals83,84 would lead to a significant reduction
in disease progression, cardiovascular events and
mortality, and health care spending on more advanced
vascular disease in secondary care. The results of
further ongoing studies (e.g. the POPADAD study) in
this respect where the ABPI is a primary endpoint are
eagerly awaited.85 ABPI could also be used selectively
to identify those individuals engaged in certain critical
occupations (e.g. heavy goods vehicle drivers, airline
pilots) who are at particularly high risk of sudden and
incapacitating cardiovascular events such as myocar-
dial infarction and stroke.Discussion
Although it is used day-in day-out across the
world in primary and secondary care, it is clear
that there is more to the ABPI than first meets the
eye and that its apparent simplicity may beguile
the unwary. In particular, care needs to be taken
with methodology and training, reproducibility,
interpretation, clinical recording and scientific
reporting. However, when used properly, the
ABPI remains an invaluable tool in assessment of
vascular patients, especially those with atypical
presentation, and in determining the success or
otherwise of surgical, endovascular and medical
interventions. But perhaps the most exciting area is
the extended utility of the ABPI as a basis for
community and occupational health screening and
the opportunities that would herald for the early
detection and evidence-based, clinically and cost-
effective, treatment of vascular disease.
Table 1. Studies examining the relationship between ABPI and cardiovascular outcome
Study NZ Cohort Study method Follow-up Major findings
McKenna M et al.74 744 Patients investigated non-
invasively for PAD
Retrospective – RR for death 2.36 if ABPI!0.85. RR for
MI 4.49 if ABPI!0.4
Vogt MT et al.75 1930 Patients agedO50 years
referred for arterial
assessment
Prospective
cohort
13 years ABPI!0.9, strong predictor for all-cause
mortality (RR for menZ1.8, RR for women
Z1.5) and CHDmortality (RR for menZ2.0,
RR for womenZ2.1)
Fishbane S et al.76 132 Haemodialysis patients Prospective
observational
1 year ABPI!0.9, RR for cardiovascular mortality
Z7.5
Leng GC et al.77 1592 Age stratified population
sample aged 55–74 years
Prospective
cohort
5 years ABPI!0.9, RR for non-fatal MIZ1.38, RR
for CVAZ1.98, RR for cardiovascular
mortalityZ1.85 and RR for all-cause
mortalityZ1.58
Newman AB et al.73 5888 Population sample aged
O65 years
Population
observational
10 years ABPI!0.9, RR for all-cause mortalityZ1.62;
incidence of cardiovascular events increase
with each ABPI decrement of 0.1
Tsai AW et al.78 14839 Population sample aged
45–64 years
Prospective
observational
7 years Overall inverse trend between ABPI and
incidence of CVA, RR for CVAZ1.93 if ABPI
!0.8
Powell J et al.79 2305 Patients with abdominal
aortic aneurysm
Prospective
observational
5.7 years RR for mortality (adjusted) increases by 1.17
per 0.2 decrement in ABPI
Jonsson B et al.80 353 Population sample aged
50–89 years
Prospective
cohort
10 years RR for all-cause mortalityZ2.1 if ABPI 0.51–
0.8, and 3.4 if ABPI! 0.5
Murabito JM et.al.81 674 Elderly healthy population:
mean age 80 years
Prospective
observational
study
4 years Significant increase in risk of CVA or TIA if
ABPI!0.9
RR, relative risk; CHD, coronary heart disease; MI, myocardial infarction; CVA, stroke; TIA, transient ischaemic attack.
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